IMS Health IPO Raises $1.3B in Second Largest Offering This Year

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn
Source: Thinkstock

Source: Thinkstock

Healthcare tech companies have been big news these days; in March, Castlight Health Inc. (NYSE:CSLT) saw its shares more than double in its first day trading after the company’s IPO. Now, IMS Health Holdings Inc. (NYSE:IMS), a 60-year-old company which makes its money selling data on prescription drug use to both drugmakers and analysts, continued the trend; the company’s shares rose 11 percent in its trading debut, and IMS and its investors managed to raise $1.3 billion after selling the stock for $20 a share, Bloomberg reports. But an earlier report from Bloomberg suggests that despite IMS’s success, analysts are skeptical about whether or not the company will succeed in “shaking up” the healthcare industry. “There’s definitely recognition that change has to happen in healthcare, so the market is rewarding innovative, disruptive models,” said Gene Mannheimer, a healthcare industry analyst based in Los Angeles, said Thursday. “I would caution that IMS is not one of their health-care disrupters.”

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business